Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1190-1192
Number of pages3
JournalMultiple Sclerosis
Volume23
Issue number9
DOIs
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this